ALNY
Alnylam Pharmaceuticals Inc.
$436.38
-$9.41(-2.11%)
38
Overall
40
Value
36
Tech
--
Quality
Market Cap
$59.82B
Volume
1.30M
52W Range
$205.87 - $495.55
Target Price
$500.33
EPS Estimates Overview
| Current Quarter | $1.01 | Next Quarter | $1.11 |
| Current Year | $1.88 | Next Year | $7.22 |
| QoQ Growth | +9.9% | YoY Growth | +284.0% |
| 3Y EPS CAGR | +32.9% | Target Price | $500.33 |
| Consensus | Buy | Upside | +14.7% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ALNY | $436.38 | -2.1% | 1.30M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Alnylam Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW